Cargando…
The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine
The uneven immunogenicity of the attenuated tetravalent dengue vaccine has made it difficult to achieve balanced protection against all four serotypes of the dengue virus (DENV). To overcome this problem, non-replicative vaccines have come into focus, as their immunogenicity is adjustable. This appr...
Autores principales: | Jearanaiwitayakul, Tuksin, Warit, Saradee, Lekjinda, Kritsadayut, Seesen, Mathurin, Limthongkul, Jitra, Midoeng, Panuwat, Sunintaboon, Panya, Ubol, Sukathida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459381/ https://www.ncbi.nlm.nih.gov/pubmed/37631912 http://dx.doi.org/10.3390/vaccines11081344 |
Ejemplares similares
-
Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021) -
Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2021) -
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
por: Jearanaiwitayakul, Tuksin, et al.
Publicado: (2022) -
Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells
por: Hunsawong, Taweewun, et al.
Publicado: (2015) -
Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study
por: Rungrojcharoenkit, Kamonthip, et al.
Publicado: (2020)